These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


630 related items for PubMed ID: 16627606

  • 1. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.
    Shanks RM, Sargent JL, Martinez RM, Graber ML, O'Toole GA.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2247-55. PubMed ID: 16627606
    [Abstract] [Full Text] [Related]

  • 2. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
    Luther MK, Mermel LA, LaPlante KL.
    Am J Health Syst Pharm; 2017 May 01; 74(9):e193-e201. PubMed ID: 28438824
    [Abstract] [Full Text] [Related]

  • 3. Activity of sodium metabisulfite against planktonic and biofilm Staphylococcus species.
    Frank KL, Patel R.
    Diagn Microbiol Infect Dis; 2007 Apr 01; 57(4):355-9. PubMed ID: 17188446
    [Abstract] [Full Text] [Related]

  • 4. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm.
    Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM.
    Infect Control Hosp Epidemiol; 2005 Jun 01; 26(6):515-9. PubMed ID: 16018425
    [Abstract] [Full Text] [Related]

  • 5. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK, Mermel LA, LaPlante KL.
    J Antimicrob Chemother; 2014 Dec 01; 69(12):3263-7. PubMed ID: 25096074
    [Abstract] [Full Text] [Related]

  • 6. Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial.
    Bosma JW, Siegert CE, Peerbooms PG, Weijmer MC.
    Nephrol Dial Transplant; 2010 Apr 01; 25(4):1213-7. PubMed ID: 19948873
    [Abstract] [Full Text] [Related]

  • 7. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections.
    Reitzel RA, Rosenblatt J, Hirsh-Ginsberg C, Murray K, Chaftari AM, Hachem R, Raad I.
    Antimicrob Agents Chemother; 2016 Sep 01; 60(9):5175-81. PubMed ID: 27297475
    [Abstract] [Full Text] [Related]

  • 8. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution.
    Balestrino D, Souweine B, Charbonnel N, Lautrette A, Aumeran C, Traoré O, Forestier C.
    Nephrol Dial Transplant; 2009 Oct 01; 24(10):3204-9. PubMed ID: 19383833
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
    LaPlante KL, Mermel LA.
    Nephrol Dial Transplant; 2007 Aug 01; 22(8):2239-46. PubMed ID: 17403700
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections.
    Takla TA, Zelenitsky SA, Vercaigne LM.
    J Antimicrob Chemother; 2008 Nov 01; 62(5):1024-6. PubMed ID: 18641034
    [Abstract] [Full Text] [Related]

  • 11. Comparison of telavancin and vancomycin lock solutions in eradication of biofilm-producing staphylococci and enterococci from central venous catheters.
    Luther MK, Mermel LA, LaPlante KL.
    Am J Health Syst Pharm; 2016 Mar 01; 73(5):315-21. PubMed ID: 26896504
    [Abstract] [Full Text] [Related]

  • 12. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus.
    Pittiruti M, Bertoglio S, Scoppettuolo G, Biffi R, Lamperti M, Dal Molin A, Panocchia N, Petrosillo N, Venditti M, Rigo C, DeLutio E.
    J Vasc Access; 2016 Nov 02; 17(6):453-464. PubMed ID: 27516141
    [Abstract] [Full Text] [Related]

  • 13. Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci.
    Frank KL, Patel R.
    Diagn Microbiol Infect Dis; 2008 Jan 02; 60(1):9-16. PubMed ID: 17889481
    [Abstract] [Full Text] [Related]

  • 14. Heparin stimulates Staphylococcus aureus biofilm formation.
    Shanks RM, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA.
    Infect Immun; 2005 Aug 02; 73(8):4596-606. PubMed ID: 16040971
    [Abstract] [Full Text] [Related]

  • 15. Superior antimicrobial activity of trisodium citrate over heparin for catheter locking.
    Weijmer MC, Debets-Ossenkopp YJ, Van De Vondervoort FJ, ter Wee PM.
    Nephrol Dial Transplant; 2002 Dec 02; 17(12):2189-95. PubMed ID: 12454232
    [Abstract] [Full Text] [Related]

  • 16. Trisodium citrate: an alternative to unfractionated heparin for hemodialysis catheter dwells.
    Pierce DA, Rocco MV.
    Pharmacotherapy; 2010 Nov 02; 30(11):1150-8. PubMed ID: 20973688
    [Abstract] [Full Text] [Related]

  • 17. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D.
    Am J Kidney Dis; 2009 Jun 02; 53(6):1034-41. PubMed ID: 19394731
    [Abstract] [Full Text] [Related]

  • 18. Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections.
    Takla TA, Zelenitsky SA, Vercaigne LM.
    J Vasc Access; 2007 Jun 02; 8(4):262-7. PubMed ID: 18161672
    [Abstract] [Full Text] [Related]

  • 19. The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.
    Raad II, Fang X, Keutgen XM, Jiang Y, Sherertz R, Hachem R.
    Curr Opin Infect Dis; 2008 Aug 02; 21(4):385-92. PubMed ID: 18594291
    [Abstract] [Full Text] [Related]

  • 20. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections.
    Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ.
    Ann Pharmacother; 2009 Feb 02; 43(2):210-9. PubMed ID: 19193593
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.